Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gert J de Borst"'
Autor:
Maarten Uyttenboogaart, Jeannette Hofmeijer, Jasper M Martens, Aad van der Lugt, Charles B L M Majoie, Marianne A A van Walderveen, Paul J Nederkoorn, Reinoud P H Bokkers, Kars C J Compagne, Gert J de Borst, Sabine L Collette, Gert Jan R Luijckx, Michael P Rodgers
Publikováno v:
Stroke and Vascular Neurology, Vol 8, Iss 3 (2023)
Background The optimal management of ipsilateral extracranial internal carotid artery (ICA) stenosis during endovascular treatment (EVT) is unclear. We compared the outcomes of two different strategies: EVT with vs without carotid artery stenting (CA
Externí odkaz:
https://doaj.org/article/dc29c0ce6c464684877144ca1837c2aa
Autor:
Michiel L Bots, N Charlotte Onland-Moret, Pim A de Jong, L Jaap Kappelle, Frank L J Visseren, Folkert W Asselbergs, Ynte M Ruigrok, Steven H J Hageman, Jan Westerink, Maarten van Smeden, Gert J de Borst, Maarten J Cramer, Jannick A N Dorresteijn, Marianne C Verhaar, Mirjam I Geerlings, Maria C Castelijns, Marga A G Helmink, Marielle H Emmelot-Vonk, Niels P van der Kaaij, A Titia Lely, Manon G van der Meer, Barend M Mol, Hendrik M Nathoe, Rutger B van Petersen, Martin Teraa, Angela Vandersteen
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Purpose The Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study is an ongoing prospective single-centre cohort study with the aim to assess important determinants and the prognosis of cardiovascular disease pro
Externí odkaz:
https://doaj.org/article/362168b1522e47a89038140cb39605ae
Autor:
Tim Leiner, Gert J de Borst, Michelle V Simons, Marijn H A Groen, Pieter A F Doevendans, Emad Ebbini, Fons J B Slieker, René van Es, Constantijn E V B Hazenberg
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/381a723c50364feab7bbc62509be1c35
Autor:
Michiel L Bots, Frank L J Visseren, Aarent RT Brand, Eline Houben, Irene D Bezemer, Ron MC Herings, Gert J de Borst
Publikováno v:
BMJ Open, Vol 11, Iss 1 (2021)
Objectives Pharmacological treatment of peripheral arterial disease (PAD) comprises of antiplatelet therapy (APT), blood pressure control and cholesterol optimisation. Guidelines provide class-I recommendations on the prescription, but there are litt
Externí odkaz:
https://doaj.org/article/caf7a57203034f5081b8656cf9e4b1cb